Nektar Therapeutics (NKTR) Long-Term Investments (2011 - 2026)
Nektar Therapeutics' Long-Term Investments was $339.06 million in Q2 2026, compared with $5.37 million a year earlier and up 108.0% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Long-Term Investments (2011 - 2026) Analysis & Trends
At the end of FY2024, Long-Term Investments at Nektar Therapeutics came in at $13.87 million, down 46.3% from FY2023.
- Long-Term Investments shows a five-year compound annual growth rate of -45.1% (FY2019 to FY2024).
- In earlier years, Long-Term Investments was $25.83 million in FY2023, $64.83 million in FY2021 (-52.6%) and $136.66 million in FY2020 (-51.0%).
- The Q2 2026 figure marks the highest quarterly Long-Term Investments since Q1 2019.
- Compared with a year earlier, Long-Term Investments was higher in 1 of the last four quarters, with an average decline of 47.7%.
- The best year-over-year quarter for Long-Term Investments over five years was Q3 2025 (growth of 6.6%); the worst was Q2 2022 (a decline of 84.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.86 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 266.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 1.22 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 69.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 2.62 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | - |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.56 Bn |
| 10 | Nektar Therapeutics | 1.55 Bn | -215.66 Mn | - | 339.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 339.06 Mn |
| Mar 31, 2026 | 162.99 Mn |
| Sep 30, 2025 | 4.84 Mn |
| Jun 30, 2025 | 5.37 Mn |
| Mar 31, 2025 | 7.76 Mn |
| Dec 31, 2024 | 13.87 Mn |
| Sep 30, 2024 | 4.54 Mn |
| Jun 30, 2024 | 19.41 Mn |
| Mar 31, 2024 | 36.78 Mn |
| Dec 31, 2023 | 25.83 Mn |
| Jun 30, 2022 | 8.93 Mn |
| Mar 31, 2022 | 37.36 Mn |
| Dec 31, 2021 | 64.83 Mn |
| Sep 30, 2021 | 34.22 Mn |
| Jun 30, 2021 | 57.40 Mn |
| Mar 31, 2021 | 96.09 Mn |
| Dec 31, 2020 | 136.66 Mn |
| Sep 30, 2020 | 197.72 Mn |
| Jun 30, 2020 | 172.17 Mn |
| Mar 31, 2020 | 185.90 Mn |
API Access
Nektar Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();